Inactive Instrument

Bioadaptives Inc Stock OTC Bulletin Board

US09072U1079

BioAdaptives, Inc. operates in the health and wellness industry. The Companyâ€™s core business is to investigate, market and distribute natural plant, fungi, and algal based products and medical devices that improve health and wellness for humans and animals, with an emphasis on pain relief, anti-viral function, and anti-aging properties. Its products in development include a weight management supplement in a human clinical trial, Zeranovia. Zeranovia is made of natural ingredients and uses proprietary methods of optimizing the availability of nutrients in foods and beverages. Xcellara regenerative stem cell activator is in production. Xcellara is its regenerative wellness solution, to enhance performance, accelerate recovery, and revitalize health. PawPa Regen is the canine treat stem cell activator. PawPa Regen supports anti-aging and wellness. Its other products include MyndMed and Wynovia. MyndMed is designed to optimize multiple neurotransmitter systems and neuroprotective pathways.

Employees

Sector

Food Processing

More about the company

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!

Market Cap	295K 256K 242K 219K 411K 28.31M 414K 2.88M 1.11M 14.36M 1.11M 1.08M 45.66M	P/E 2024	-0.55x	P/E 2025	-0.14x
Enterprise Value	521K 452K 426K 387K 726K 49.97M 731K 5.09M 1.96M 25.35M 1.96M 1.92M 80.59M	EV / Sales 2024	55.1x	EV / Sales 2025	26.9x
Free-Float	5.04%	Yield 2024 *	-	Yield 2025	-

08-19	BioAdaptives, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-16	BioAdaptives Outlines Xcellara Platform Strategy And Announces Commercial Launch Of XcellaraHeart	CI
07-15	Bioadaptives Inc Announces Commercial Availability of Xcellaraheart Cardiovascular Wellness Formula	CI
06-25	BioAdaptives Completes MyndRenew Platform with TruShield Certification of MyndRenew Securing Full Wada Compliance	CI
05-20	Bioadaptives Inc Launches Myndsystem Platform	CI
05-15	BioAdaptives, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-06	BioAdaptives, Inc. Launches MyndRenew to Complete the 24-Hour Brain Performance Cycle	CI
04-28	BioAdaptives Inc Announces Launch of Myndsystem	CI
04-14	BioAdaptives, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-13	BioAdaptives, Inc. Auditor Raises 'Going Concern' Doubt	CI
11-14	BioAdaptives, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-10-07	BioAdaptives, Inc. Announces Commercial Launch of MyndMed Following Successful Pilot Testing	CI
25-08-20	BioAdaptives' MyndMed Receives Full Clearance from TruShield??, Meeting UFC and WADA Standards for Athlete Safety	CI

09-03	BioAdaptives Confirms First Commercial Orders of XcellaraHeart(TM) and Outlines Capital Restructuring Progress	AQ
08-31	UFC Hall of Famer Michael Bisping Joins BioAdaptives to Champion MyndSystem(TM)	AQ
08-13	BioAdaptives, Inc. Announces CEO's Share Cancellation and Provides Capital Restructure Update	AQ
08-12	BioAdaptives Inc. Introduces XcellaraHeart(TM): the World's First Stem Cell Mobilizer with a Targeted Cardiac Homing Signal	AQ
08-04	BioAdaptives Explains the Scientific Basis of the Dual-Action Xcellara(TM) "Supply and Direction" Platform	AQ

Manager	Title	Age	Since
James Keener CEO	Chief Executive Officer	55	2024-05-20
Emily Harrison IRC	Investor Relations Contact	-	-
Antonina Nabokova PRN	Corporate Officer/Principal	63	-

Director	Title	Age	Since
Gimhana Dissanayake BRD	Director/Board Member	53	2024-05-29
James Keener CHM	Chairman	55	2024-05-20
Mark Frissora BRD	Director/Board Member	70	2025-02-02

Bioadaptives Inc Stock OTC Bulletin Board

Stocks

US09072U1079

Food Processing

Valuation: Bioadaptives Inc

Latest news: Bioadaptives Inc

Press Releases: Bioadaptives Inc

Quotes and Performance

Managers and Directors: Bioadaptives Inc

Special Foods & Wellbeing Products

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
BIOADAPTIVES INC	+1.45%	+0.45%	-	-	315K
ZHEJIANG NHU COMPANY LTD.	+1.55%	+1.55%	+6.87%	+64.35%	12.13B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+2.64%	-4.18%	-17.03%	+244.49%	8.8B
BYHEALTH CO., LTD	0.00%	-5.49%	-23.35%	-50.98%	2.32B
XIAMEN KINGDOMWAY GROUP COMPANY	+3.07%	-2.67%	-15.35%	-8.26%	1.43B
JAMIESON WELLNESS INC.	-0.09%	+0.07%	+22.14%	+73.98%	1.36B
HERBALIFE LTD.	+0.25%	-2.67%	+26.05%	-19.72%	1.26B
BELLRING BRANDS, INC.	+0.66%	-11.45%	-75.83%	-77.82%	1.06B
TSI GROUP CO., LTD.	+3.58%	-8.93%	-45.86%	-	998M
THE SIMPLY GOOD FOODS COMPANY	+1.02%	-13.19%	-63.38%	-71.12%	870M
Average	+1.41%	-5.21%	-20.64%	+19.36%	3.36B
Weighted average by Cap.	+1.71%	-2.40%	-8.64%	+93.49%

	2024	2025
Net sales	12.67K 10.98K 10.36K 9.4K 17.63K 1.21M 17.76K 124K 47.68K 616K 47.58K 46.53K 1.96M	18.28K 15.84K 14.95K 13.56K 25.44K 1.75M 25.62K 179K 68.78K 889K 68.65K 67.14K 2.83M
Net income	-899K -779K -735K -667K -1.25M -86.18M -1.26M -8.78M -3.38M -43.72M -3.38M -3.3M -139M	-1.56M -1.35M -1.27M -1.16M -2.17M -149M -2.18M -15.21M -5.86M -75.75M -5.85M -5.72M -241M
Net Debt	206K 178K 168K 153K 286K 19.71M 288K 2.01M 774K 10M 772K 755K 31.79M	226K 196K 185K 168K 314K 21.66M 317K 2.21M 850K 10.99M 849K 830K 34.93M